Rocket Pharmaceuticals Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.14

-0.25 (-5.69%)

As of Mar 22, 10:27 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 12 57%

Hold 7 33%

Sell 2 10%

Price Target

Analyst Price Target +307.5% upside

Low Target $13.87

Average Target $16.87

High Target $23.44

Current Price $4.14

Current
$4.14

Target
$16.87

$13.87 $16.87 avg $23.44

Scenario Analysis

Bear Case

$13.87

235.0%

Low target

Base Case

$16.87

+307.5%

Avg target

Bull Case

$23.44

+466.2%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$9.35

-55.7% from high

52-Week Low

$2.19

+89.0% from low

Target vs 52W High

$16.87

+80.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%